FIIs turn bullish on NBFCs, cap goods
* FIIs raise stakes in 20 sectors * Cut exposure to IT, pharma * Go light on auto, construction materials
D-Street week ahead: Nifty may see tech pullbacks, but no major surge
From the peak, VIX has corrected 51 per cent, while Nifty remains at el...
Lodha Group, ESR in 50:50 JV to develop $100mn industrial park
The 50:50 joint venture between the two companies will develop 89 acres of lan...
Sun Pharma falls 4% as Goldman Sachs downgrades stock
Shares of Sun Pharma traded 4.31 per cent down at Rs 384.55 on BSE.
After IT & pharma, chemicals likely to score big on exports
Reflecting the trend, shares of Indian chemical companies have hit record highs.
Hold Sun Pharmaceutical Industries, target Rs 460: ICICI Direct
Sun Pharmaceutical Industries is a largecap company, operating in pharmaceuticals and health care sector.
Buy Sun Pharmaceutical Industries, target Rs 520: CLSA
Sun Pharma is a largecap company, operating in pharmaceuticals and health care sector.
Buy Sun Pharma, target Rs 511: KR Choksey Securities
Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 511.0 .
F&O: Nifty50 needs to stage a decisive breakout to hit the 12,040 level
Nifty has been consolidating in 11,800 to 11,970 range from the last four trading sessions.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service